INDP

Indaptus Therapeutics (INDP)

Indaptus Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:INDP

1 2 3 4 5 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/06/11	21:00	GlobeNewswire Inc.	Indaptus Therapeutics to Present Positive Data on Lead Product Candidate, Decoy20, at STING & TLR-Targeted Therapies Summit	NASDAQ:INDP	Indaptus Therapeutics Inc
2024/06/08	06:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INDP	Indaptus Therapeutics Inc
2024/06/08	05:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INDP	Indaptus Therapeutics Inc
2024/06/04	21:00	GlobeNewswire Inc.	Indaptus Therapeutics to Present New Positive Data on Decoy20 at Next-Gen Immuno-Oncology Conference	NASDAQ:INDP	Indaptus Therapeutics Inc
2024/06/03	21:00	GlobeNewswire Inc.	Indaptus Therapeutics Announces New Positive Data from Ongoing Phase 1 Trial of Decoy20	NASDAQ:INDP	Indaptus Therapeutics Inc
2024/05/30	21:00	GlobeNewswire Inc.	Indaptus Therapeutics to Present at the Jefferies Global Healthcare Conference	NASDAQ:INDP	Indaptus Therapeutics Inc
2024/05/29	21:00	GlobeNewswire Inc.	Indaptus Therapeutics to Present New Cohort Data Confirming Original “Pulse-Prime” Hypothesis Via Phase 1 Clinical Trial of Decoy20 at the American Society of Clinical Oncology Annual Meeting	NASDAQ:INDP	Indaptus Therapeutics Inc
2024/05/22	21:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INDP	Indaptus Therapeutics Inc
2024/05/22	21:00	GlobeNewswire Inc.	Indaptus Therapeutics Announces Completion of First Patient to Receive Multiple Doses of Decoy20, the Company’s Broad-Based, “Pulse-Prime” Immuno-Oncology Therapy for Advanced Solid Tumors	NASDAQ:INDP	Indaptus Therapeutics Inc
2024/05/08	21:06	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:INDP	Indaptus Therapeutics Inc
2024/05/08	21:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INDP	Indaptus Therapeutics Inc
2024/05/08	21:00	GlobeNewswire Inc.	Indaptus Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update	NASDAQ:INDP	Indaptus Therapeutics Inc
2024/04/11	20:30	GlobeNewswire Inc.	Indaptus Therapeutics Presents Positive Mechanism of Action Data at the American Association for Cancer Research Annual Meeting	NASDAQ:INDP	Indaptus Therapeutics Inc
2024/03/28	21:00	GlobeNewswire Inc.	Indaptus Therapeutics to Present at the MedInvest Biotech and Pharma Investor Conference	NASDAQ:INDP	Indaptus Therapeutics Inc
2024/03/25	21:30	GlobeNewswire Inc.	Indaptus Therapeutics Previews Positive Mechanism of Action Data to be Presented at the American Association for Cancer Research Annual Meeting	NASDAQ:INDP	Indaptus Therapeutics Inc
2024/03/18	21:00	GlobeNewswire Inc.	Indaptus Therapeutics to Participate in Tribe Public Webinar On Wednesday, March 20, 2024	NASDAQ:INDP	Indaptus Therapeutics Inc
2024/03/13	20:30	GlobeNewswire Inc.	Indaptus Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update	NASDAQ:INDP	Indaptus Therapeutics Inc
2024/03/05	01:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INDP	Indaptus Therapeutics Inc
2024/03/04	21:30	GlobeNewswire Inc.	Indaptus Therapeutics Announces Positive Results from Second Cohort of Phase 1 Trial; Company Initiates Multi-Dose Cohort	NASDAQ:INDP	Indaptus Therapeutics Inc
2024/02/15	22:00	GlobeNewswire Inc.	Indaptus Therapeutics to Present at the 2024 BIO CEO & Investor Conference	NASDAQ:INDP	Indaptus Therapeutics Inc
2024/02/08	22:00	GlobeNewswire Inc.	Indaptus Therapeutics Expands Digital Presence with Launch of Social Media Channels	NASDAQ:INDP	Indaptus Therapeutics Inc
2024/01/24	06:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INDP	Indaptus Therapeutics Inc
2024/01/24	06:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INDP	Indaptus Therapeutics Inc
2024/01/04	22:00	GlobeNewswire Inc.	European Patent Office Approves Key Patent for Indaptus Therapeutics’ Platform Technology	NASDAQ:INDP	Indaptus Therapeutics Inc
2023/11/07	06:06	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:INDP	Indaptus Therapeutics Inc
2023/11/07	06:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INDP	Indaptus Therapeutics Inc
2023/11/07	06:01	GlobeNewswire Inc.	Indaptus Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update	NASDAQ:INDP	Indaptus Therapeutics Inc
2023/11/06	22:13	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INDP	Indaptus Therapeutics Inc
2023/11/06	22:00	GlobeNewswire Inc.	Indaptus Therapeutics’ Decoy20 Demonstrated a Broad Immune Response of More than Fifty Cytokines and Chemokines in Patients Following a Single Dose in First Cohort of Ongoing Phase 1 Study	NASDAQ:INDP	Indaptus Therapeutics Inc
2023/10/31	22:12	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INDP	Indaptus Therapeutics Inc